fara co-funds new Research Programs & extended other grants into their second years
fara co-funded four new Research Programs & extended three other grants into their second years in 2022/2023
SKYCLARYS to be Assessed by PBAC
Biogen to Acquire Reata Pharmaceuticals
fara co-funded four new Research Programs & extended three other grants into their second years in 2022/2023